Kura Oncology
KURA
10.40
-0.27
-2.55%
Kura Oncology
US · KURA
#3283 by market cap
Listed 2015
10.40
-0.27
-2.55%
Live - 5344 symbols - heartbeat 523s ago
· 2026-10-08 09:59
Pre-market
10.48
-1.78%
After-hours
10.67
0.00%
- Market cap
- 925.01M
- P/E (TTM)i
- -3.09
- P/Bi
- 19.11
- EPSi
- -3.18
- Div yieldi
- 0.00%
- 52W posi
- 46%
Reader sentiment
Are you bullish or bearish on KURA?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
Rating change
H.C. Wainwright Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $40Market Newswire · 2026/9/9
-
Company notice
Speee: Secret remittance demo "Kura Pay" and the beta version of "KuraPrivacy Service API" are now available.JPX · 2026/7/29
-
William Blair Maintains Kura Sushi USA(KRUS.US) With Buy RatingMarket Newswire · 2026/9/23
-
Rating change
A Quick Look at Today's Ratings for Kura Oncology(KURA.US), With a Forecast Between $28 to $40Market Newswire · 2026/8/13
-
Rating change
BofA Securities Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $30Market Newswire · 2026/7/22
-
Rating change
Wedbush Maintains Kura Oncology(KURA.US) With Buy Rating, Raises Target Price to $36Market Newswire · 2026/7/29
-
Company notice
Kura Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Powl Brian T.SEC · 2026/5/23
-
Rating change
Barclays Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $28Market Newswire · 2026/9/10
-
Rating change
Lake Street Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $23Market Newswire · 2026/9/10
-
Rating change
Kura Sushi, Inc. (2695) Receives a Hold From Mizuho SecuritiesTipRanks · 2026/9/16
-
BofA Securities Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $31Market Newswire · 2026/9/30
-
J.P. Morgan Initiates Kura Oncology(KURA.US) With Buy Rating, Announces Target Price $30Market Newswire · 2026/10/1
-
Company notice
4: Kura Oncology | 4: Statement of changes in beneficial ownership of securities-Director Parks Diane L.SEC · 2026/6/5
-
SBI Securities Keeps Their Buy Rating on Kura Sushi, Inc. (2695)TipRanks · 2026/9/28
-
Rating change
Mizuho Securities Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $25Market Newswire · 2026/8/31
-
Rating change
Craig-Hallum Maintains Kura Sushi USA(KRUS.US) With Buy Rating, Announces Target Price $80Market Newswire · 2026/7/8
-
Rating change
A Quick Look at Today's Ratings for Kura Oncology(KURA.US), With a Forecast Between $23 to $40Market Newswire · 2026/8/14
-
Company notice
Commerce One Holdings: We have begun offering a data integration option for the multi-store e-commerce management system "Tsūhan suru Kura" and "TikTok Shop."JPX · 2026/7/16
-
Company notice
Kura Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Powl Brian T.SEC · 2026/9/30
-
UBS Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $15Market Newswire · 2026/8/21
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-08 09:59:52 · For reference only, not investment advice and not tailored to your situation.